Results 221 to 230 of about 28,521 (342)

The application of biomarkers in hereditary transthyretin amyloidosis – an ongoing research project on bulgarian patients

Българска неврология
The current research project is being conducted in IMDL Genome Center Bulgaria / GMDL Genica (part of the Expert Centers for ATTR in Bulgaria1). It aims at advancing the accurate prognosis and monitoring of the onset and progression of hereditary ...
Z. Pavlova, A. Ormandjieva, C. Georgiev, O. Asenov, A. Taneva, T. Chamova, I. Tournev, Albena Todorova   +7 more
doaj  

Motor phenotypes and neurofilament light chain in genetic amyotrophic lateral sclerosis—results from a multicenter screening program [PDF]

Philipp Schmitt, Peggy Schumann, Alexander Koerbs, Hsuen-Ju Lin, Torsten Grehl, Ute Weyen, Susanne Petri, Annekathrin Rödiger, Robert Steinbach, Julian Großkreutz, Sarah Bernsen, Patrick Weydt, Joachim Wolf, René Günther, Petra Baum, Moritz Metelmann, Jochen H. Weishaupt, Berthold Streubel, David C. Kasper, Yasemin Koc, Dagmar Kettemann, Jenny Nordén, Bertram Walter, Christoph Münch, Susanne Spittel, André Maier, Péter Körtvelyessy, Thomas Meyer   +27 more
openalex   +1 more source

Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor [PDF]

, 1991
BG Gold, WC Mobley, Stephen Matheson
openalex   +1 more source

RB1 inactivation in cutaneous carcinomas

Histopathology, EarlyView.
Among skin carcinomas, recurrent RB1 inactivation is observed in Merkel cell carcinoma, in a subset of squamous cell carcinoma with bowenoid morphology, in sebaceous carcinoma and in the recently described Wnt/beta‐catenin rosette‐forming carcinoma.
Tiffany Liv, Antoine Touzé, David Schrama, Serge Guyétant, Mahtab Samimi, Michael T Tetzlaff, Benjamin A Wood, Paul W Harms, Thibault Kervarrec   +8 more
wiley   +1 more source

Neurofilament heavy chain in secondary progressive multiple sclerosis. [PDF]

Mult Scler
De Angelis F, Ammoscato F, Parker RA, Plantone D, Doshi A, John NA, Williams T, Stutters J, MacManus D, Schmierer K, Barkhof F, Weir CJ, Giovannoni G, Chataway J, Gnanapavan S.   +14 more
europepmc   +1 more source

Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons [PDF]

, 1989
Joab Chapman, O. Bachar, Amos D. Korczyn, E. Wertman, DM Michaelson   +4 more
openalex   +1 more source

Elevated neurofilament light levels in acute anorexia nervosa are associated with alterations in white matter volume and connectivity networks

Journal of Child Psychology and Psychiatry, EarlyView.
Background Anorexia nervosa (AN) is a severe eating disorder associated with drastic reductions in gray and white matter (WM) volume and structural connectivity alterations. However, the hypotheses regarding underlying mechanisms are inconclusive. The current study investigated the relationships of WM volume as well as WM network architecture with ...
Inger Hellerhoff, Daniel Geisler, Fabio Bernardoni, Arne Doose, Friederike I. Tam, David M. Poitz, Nina Chotjewitz, Veit Roessner, Katja Akgün, Tjalf Ziemssen, Stefan Ehrlich   +10 more
wiley   +1 more source

Delirium pathophysiology in cancer: neurofilament light chain biomarker - narrative review. [PDF]

BMJ Support Palliat Care
Kruize Z, van Campen I, Vermunt L, Geerse O, Stoffels J, Teunissen C, van Zuylen L.   +6 more
europepmc   +1 more source

Combinatorial targeting of MYC/BCL2‐associated vulnerabilities in high‐grade B‐cell lymphoma

British Journal of Haematology, EarlyView.
Giulio Donati, Paola Nicoli, Federica Miele, Paola Podini, Giorgia Dina, Angelo Quattrini, Bruno Amati   +6 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source